Back to Search Start Over

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

Source :
GlobeNewswire. May 9, 2024
Publication Year :
2024

Abstract

Patient dosed with TSC-20 3 -A0201 targeting cancer-associated antigen PRAME On-track to report initial data from the solid tumor clinical trial in 2024 WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) [...]

Subjects

Subjects :
T cells
Tumors -- Drug therapy
Cancer patients -- Drug therapy
Antigens
Clinical trials
Melanoma -- Drug therapy
Banking, finance and accounting industries
Business

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.793190210

Tools

Authors Abstract Subjects Details